CRISPR-Cas9 (AA 1-200) Antikörper

Produktnummer ABIN6942685

Der Kaninchen Monoklonal Anti- Antikörper wurde für WB validiert. Er ist geeignet, in Proben von Others zu detektieren.

Kurzübersicht für CRISPR-Cas9 (AA 1-200) Antikörper (ABIN6942685)

Target: CRISPR-Cas9

Reaktivität: Others

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: Western Blotting (WB)

Klon: 6C1

Produktdetails

Bindungsspezifität: AA 1-200

Kreuzreaktivität: Human

Kreuzreaktivität (Details): Streptococcus pyogenes

Aufreinigung: Purified by Protein A.

Immunogen: CRISPR-Cas9 between 1-200 amino acids

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB(1:300-1000)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 1xTBS ( pH 7.4), 1 % BSA, 40 %Glycerol and 0.05 % Sodium Azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Antigendetails

Target: CRISPR-Cas9

Andere Bezeichnung: CRISPR-Cas9 SP

Hintergrund:

Synonyms: CRISPR-associated endonuclease Cas9/Csn1, SpCas9, SpyCas9, cas9

Background: CRISPR (clustered regularly interspaced short palindromic repeat) is an adaptive immune system that provides protection against mobile genetic elements (viruses, transposable elements and conjugative plasmids) (PubMed:21455174). CRISPR clusters contain spacers, sequences complementary to antecedent mobile elements, and target invading nucleic acids. CRISPR clusters are transcribed and processed into CRISPR RNA (crRNA). In type II CRISPR systems correct processing of pre-crRNA requires a trans-encoded small RNA (tracrRNA), endogenous ribonuclease 3 (rnc) and this protein. The tracrRNA serves as a guide for ribonuclease 3-aided processing of pre-crRNA, Cas9 only stabilizes the pre-crRNA:tracrRNA interaction and has no catalytic function in RNA processing (PubMed:24270795). Subsequently Cas9/crRNA/tracrRNA endonucleolytically cleaves linear or circular dsDNA target complementary to the spacer, Cas9 is inactive in the absence of the 2 guide RNAs (gRNA). The target strand not complementary to crRNA is first cut endonucleolytically, then trimmed 3'-5' exonucleolytically. DNA-binding requires protein and both gRNAs, as does nuclease activity. Cas9 recognizes the protospacer adjacent motif (PAM) in the CRISPR repeat sequences to help distinguish self versus nonself, as targets within the bacterial CRISPR locus do not have PAMs. DNA strand separation and heteroduplex formation starts at PAM sites, PAM recognition is required for catalytic activity (PubMed:24476820). Confers immunity against a plasmid with homology to the appropriate CRISPR spacer sequences (CRISPR interference) (PubMed:21455174).

Gen-ID: 901176

UniProt: Q99ZW2